Different types of adjuvants in prophylactic and therapeutic human papillomavirus vaccines in laboratory animals: a systematic review

Human papillomavirus (HPV) causes cervical carcinoma, which and is the third most common cancer, accounting for 275,000 deaths annually worldwide. Adjuvants have a key role in promotion of vaccine efficacy; therefore, using prophylactic and therapeutic vaccines combined with adjuvant could be of gre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of virology 2020-02, Vol.165 (2), p.263-284
Hauptverfasser:	Mousavi, Tahoora, Sattari Saravi, Sogol, Valadan, Reza, Haghshenas, Mohammad Reza, Rafiei, Alireza, Jafarpour, Hamed, Shamshirian, Amir
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants Adjuvants, Immunologic - administration & dosage Animals Animals, Laboratory Biomedical and Life Sciences Biomedicine Cervical cancer Cervical carcinoma Cervix Chitosan Cholera toxin Colony-stimulating factor Combined vaccines Cytotoxicity Disease Models, Animal Female Granulocyte-macrophage colony-stimulating factor Heat shock proteins Heat-labile enterotoxin Human papillomavirus Infectious Diseases ISCOMS Laboratory animals Lymphocytes T Medical Microbiology Papillomaviridae - immunology Papillomavirus Infections - complications Papillomavirus Vaccines - administration & dosage Review Ribonucleic acid RNA Toll-like receptors Treatment Outcome Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - therapy Vaccine efficacy Vaccines Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!